Bethany M.
Schwandt
,
PhD
1750 E. Fairmount Avenue
Baltimore, MD 21231
United States
About
Dr. Bethany Schwandt is a pediatric neuropsychologist in the Department of Neuropsychology at Kennedy Krieger Institute. She provides neuropsychological evaluations for individuals ranging from infant and toddler age to young adults with neurodevelopmental and medical conditions that affect cognitive functioning, primarily through the Oncology and Epilepsy Clinics.
Education
Dr. Schwandt earned a bachelor’s degree in psychology at North Dakota State University. She worked as a research assistant exploring infant cognitive development and differences in pupil dilation and emotion dysregulation among victimized children. She continued clinical work for a few years in a psychiatric residential treatment facility for youth before returning to graduate school. She completed her graduate training at Ball State University in Indiana where she received a PhD in School Psychology with a specialty cognate in pediatric neuropsychology. She completed her APA-accredited predoctoral internship at Fraser Child and Family Center in Minneapolis, Minnesota, a specialty clinic working with neurodevelopmental disorders and early childhood assessment. She completed a two-year pediatric neuropsychology fellowship at St. Jude Children’s Research Hospital. There, she also completed a clinical rotation and participated in research on the Epilepsy Monitoring Unit (EMU) at Le Bonheur Children’s Hospital.
Research
Dr. Schwandt’s research interests center around assessment and intervention across areas of oncology, epilepsy, early childhood and neurodevelopment. Dr. Schwandt completed research projects on fellowship involving examining memory and other cognitive late effects for patients treated for craniopharyngioma, ependymoma, medulloblastoma, posterior fossa syndrome and encephalitis following repeated BMT. She is currently involved in the early childhood developmental assessments for the HEALthy Brain and Child Development Study (HBCD) at Kennedy Krieger. The project particularly assesses the effects of early life exposure to opioids, marijuana, alcohol and/or other substances on neurodevelopment.